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ABSTRACT:  1 
It is essential to develop a simple synthetic strategy to improve the quality of 2 
multifunctional contrast agents for cancer diagnosis. Herein, we report a time-saving 3 
method for gadolinium (Gd3+) ions-mediated self-assembly of gold nanoclusters 4 
(GNCs) into monodisperse spherical nanoparticles (GNCNs) under mild conditions. 5 
The monodisperse, regular and colloidal stable GNCNs were formed via selectively 6 
inducing electrostatic interactions between negatively-charged carboxylic groups of 7 
gold nanoclusters and trivalent cations of gadolinium in aqueous solution. In this way, 8 
the Gd3+ ions were chelated into GNCNs without the use of molecular gadolinium 9 
chelates. With the co-existence of GNCs and Gd3+ ions, the formed GNCNs exhibit 10 
significant luminescence intensity enhancement for near-infrared fluorescence (NIRF) 11 
imaging, high X-ray attenuation for computed tomography (CT) imaging and 12 
reasonable r1 relaxivity for magnetic resonance (MR) imaging. The excellent 13 
biocompatibility of the GNCNs was proved both in vitro and in vivo. Meanwhile, the 14 
GNCNs also possess unique NIRF/CT/MR imaging ability in A549 tumor-bearing 15 
mice. In a nutshell, the simple and safe GNCNs hold great potential for tumor 16 
multi-modality clinical diagnosis. 17 
Keywords: Gold nanoclusters (GNCs) ·  Gd3+ ions ·  Assembly ·  Multi-modality 18 
imaging · Diagnosis 19 
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1. Introduction 1 
Nowadays, there is an increasing interest in the development of molecular imaging 2 
technology for applications in early-stage cancer imaging diagnosis[1, 2]. Among 3 
various imaging modalities, near-infrared fluorescence (NIRF)[3], computed 4 
tomography (CT)[4] and magnetic resonance (MR)[5] imaging are three of the most 5 
widely used imaging techniques for disease diagnosis. NIRF imaging possesses high 6 
sensitivity. But it cannot guarantee an adequate spatial resolution [6]. CT imaging is a 7 
time-saving and low cost imaging technique with excellent density and spatial 8 
resolution. Despite of high-resolution images of anatomic structures, CT imaging is 9 
trapped in soft-tissue imaging applications due to the inadequacy of sensitivity [4]. 10 
Besides, MR imaging is a non-invasive technique with high sensitivity, good tissue 11 
penetration depth, and detailed profile ability of soft-tissues. But it is unable to detect 12 
lesions of bone structures [7]. Due to the limitations of the individual imaging technique 13 
discussed above, the use of dual mode or multimode imaging is indispensable for 14 
comprehensive and accurate cancer diagnosis, especially for early-stage cancer 15 
diagnosis [8-10]. To present day, the development of nanoparticle-based contrast agents 16 
provide a promising way to integrate the advantages of different imaging techniques for 17 
accurate cancer diagnosis and for extending the application scope of molecular 18 
imaging[11-14]. Nevertheless, most of the contrast agents used in the clinic are only 19 
suitable for single modality imaging. Meanwhile, complicated architectures and 20 
synthetic processes are always required to synthesize multifunctional nanoparticle-based 21 
contrast agents for multi-modality cancer diagnosis [11, 15, 16]. Thus, the development 22 
of a simple and time-saving protocol to synthesize a single nanostructure bearing 23 
various contrast agents for different imaging modalities would bring a great 24 
improvement towards an accurate cancer diagnosis. 25 
Among the numerous nanoparticles described nowadays [12, 13, 17, 18], the noble 26 
metal nanoclusters (NCs) are ultrasmall nanoparticles (with a core size smaller than 2 27 
nm) with well-defined sizes, components and charges[19, 20]. They possess strong 28 
luminescence and enhanced catalytic activity which make them especially attractive in 29 
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biomedical areas for biosensing[21], bioimaging [22, 23], and therapy [24, 25]. 1 
Generally speaking, polymers, dendrimers, biological molecules or polyelectrolytes are 2 
the main templates used to synthesize NCs in solution [24, 26-28]. Glutathione 3 
(GSH)-capped gold nanoclusters (GNCs) are one kind of noble metal nanoclusters that 4 
are synthesized using glutathione as thiolate ligand, and can be denoted as Aun(SG)m 5 
(where n is the number of gold atoms, and m is the number of glutathione molecules) 6 
[29-31]. The GNCs composed of a dozen to about a hundred gold atoms possess many 7 
advantages for biomedical applications, such as excellent biocompatibility, good water 8 
solubility, faster clearance by normal tissues, longer retention time in the tumor, and 9 
easily functionalized surface ligands [26, 32, 33]. Moreover, the intrinsic characteristics 10 
of GNCs, red-near-infrared fluorescence, large two-photon excitation and excellent 11 
X-ray attenuation, make them highly suitable for both in vitro and in vivo NIRF and CT 12 
imaging [29, 33-35]. Therefore, the GNCs may have a great potential for multi-modality 13 
cancer diagnosis. Nowadays, the lanthanide ion Gd3+ based contrast agents have been 14 
widely studied for cancer diagnosis [16, 36, 37]. But the development of sensitive, 15 
biocompatible, and stable Gd3+-based contrast agents without the use of molecular 16 
gadolinium chelates still remains as an interesting approach and great challenge. Based 17 
on the qualities of GNCs and lanthanide Gd3+ ions, an exciting methodology for 18 
biomedical applications could be development of an effective and simple method to 19 
assemble GNCs and Gd3+ ions into a single multifunctional spherical nanoparticle for 20 
cancer multi-modality imaging. According to a previous report [38], the GNCs could be 21 
assembled into monodisperse and uniform spheres via selectively inducing interaction 22 
of electrons between divalent cations and negatively-charged GNCs. In this scenario, 23 
the GNCs can sever as a new family of ion mimics (‘‘nanoions’’) in aqueous solution 24 
where the self-assemble process is analogous to the theory of formation of ionic crystals 25 
from real ions. Using the above theory, the hydrophilic GNCs could be assembled into 26 
monodisperse spherical shapes via the strong interaction of electrons between 27 
negatively-charged GNCs and trivalent counter cations of gadolinium. If properly 28 
implemented, this method to combine GNCs and Gd3+ ions would be a simple and 29 
time-saving approach to assemble them into a single nanoparticle for multi-modality 30 
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tumor imaging. 1 
Herein, we report the assembly of gold nanoclusters into monodisperse regular and 2 
stable spherical nanoparticles (GNCNs) by a selective electrostatic interaction for 3 
enhanced tumor multi-modality imaging (scheme 1). This simple and time-saving 4 
electrostatic interaction occurs between negatively-charged carboxylic groups on the 5 
gold nanoclusters and trivalent cations of gadolinium (Gd3+) in aqueous solution under 6 
mild conditions. The assembly behavior only occurs when the ratio of Gd3+ ions and 7 
carboxylate groups exceeds certain threshold values. Such behavior is different from the 8 
random aggregation of colloidal nanoparticles by counter ions. With the co-existence of 9 
GNCs and Gd3+ ions, the formed GNCNs exhibit an enhanced fluorescence, high X-ray 10 
attenuation and reasonable r1 relaxivity. All of these properties ensure that GNCNs 11 
could be used as NIRF/CT/MR multi-modality imaging contrast agents for accurate 12 
diagnosis of different types of tumor. The physicochemical properties of the synthesized 13 
GNCNs were extensively characterized via various techniques. In addition, both in vitro 14 
and in vivo experiments are carried out to carefully evaluate the biocompatibility, 15 
cellular uptake efficacy and tumor NIRF/CT/MR multi-modality imaging performance. 16 
We believe that the multifunctional spherical GNCNs are novel, simple and safe 17 
nanoparticles, which hold great potential for cancer NIRF/CT/MR multi-modality 18 
clinical diagnose.  19 
2. Materials and methods 20 
2.1. Materials  21 
Tetrabutylammonium borohydride (TBAB; 95%) and Gadolinium chloride 22 
hexahydrate (GdCl3·6H2O) were obtained from Aladdin Reagent Co. Ltd. (Shanghai 23 
China). Sephadex G-150 was purchased from Pharmacia (Uppsala, Sweden). 24 
3-[4,5-Dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT), Gold chloride 25 
trihydrate (HAuCl4·3H2O, 99%) and Hoechst 33342 were received from Sigma 26 
Chemical Corporation (St Louis, USA). The reagents related to cell culture were 27 
obtained from Hyclone. Ultrapure water with resistivity of 18.2 MΩ was used in the 28 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
preparation of all aqueous solutions. 1 
2.2. Synthesis of red-emitting GNCs  2 
The procedure to synthesize red-emitting GNCs is similar to our previous study 3 
[24]. Briefly, the freshly prepared HAuCl4 (5 mL, 0.02 M) and GSH (2 mL, 0.15 M ) 4 
were diluted with 87 mL cold deionized water under vigorous stirring for 3 min. Then 5 
the mixture was added with icy cold TBAB solution (6 mL, 0.186 M) under a quickly 6 
vigorous stirring for 5 min. After the mixture was maintained for 2 h without vigorous 7 
stirring in ice bath, 1M HCl was added to adjust the pH of the reaction to about 3.0. 8 
Then the insoluble Au(I)−thiolate complex were separated by centrifugation. After 9 
another 12 h incubation of the mixture in ice bath, the supernatant was added with NaCl 10 
(to about 10 × 10–3 M ) and cold methyl alcohol to collect the precipitates. The 11 
precipitates were dialyzed for three days against ultrapure water to obtain the GNCs.  12 
2.3. Gd (III) ions-induced assembly of red-emitting GNCs  13 
Before the reaction, the above prepared GNCs (1.25 mg/mL) and the GdCl3·6H2O 14 
in specific concentration were dissolved in the aqueous solution, respectively. Then the 15 
pH of the each solution was adjusted to about 6.5. The GdCl3 solution was freshly 16 
prepared and sonicated for 3 min by an ultrasonicator at 100 W before used. Taking 17 
R[Gd3+]/[GSH] =0.08 as an example, 0.25mL of 0.73 mM GdCl3 aqueous solution was 18 
added dropwise into GNCs aqueous solution (1.25 mg/mL,1mL) under stirring and 19 
maintained at 30 oC for 3 h. The gel filtration method (Sephadex G-150 column 20 
equilibrated with the ultrapure water) was used to purify the assembled GNCs (GNCNs). 21 
Assembly of GNCs by Gd3+ ions in other concentration was also synthesized in the 22 
similar steps. 23 
2.4. Characterization 24 
The size and the morphology of GNCNs were evaluated by transmission electron 25 
microscopy (TEM), high resolution TEM (HR-TEM) and field emission scanning 26 
electron microscopy (SEM). The composition of GNCNs was measured by 27 
energy-dispersive X-ray spectroscopy (EDX) and scanning transmission electron 28 
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microscopy (STEM). PL spectra were characterized by a Hitachi FL-4600 1 
spectrofluorometer. UV-vis spectra were tested with a Varian Cary 50 2 
spectrophotometer (Varian Inc., USA). The size and ζ-potential of GNCNs were 3 
estimated by a Nicomp 380 ZLS Zeta potential/Particle sizer (PSS Nicomp, USA). 4 
Moreover, the aqueous solution of GNCs, GNCNs, Omnipaque and Gd-DTPA were 5 
prepared into Eppendorf tubes (1.5 mL) with different concentrations before CT or MR 6 
imaging. The dual-source CT system (SOMATOM Definition Flash, Siemens, Erlangen, 7 
Germany) was used to perform the CT scanning with the parameters set to 100 kV, 80 8 
mA, and a slice thickness of 0.625 mm. Hounsfield units (HU) for the regions of 9 
interest were used to determine the contrast enhancement of each sample and each 10 
sample was measured for 3 times. The T1 relaxation times of the GNCNs and Gd-DTPA 11 
with different Gd3+ concentrations was performed using a 0.5T NMI20-Analyst NMR 12 
Analyzing and Imaging system (Shanghai Niumag Corporation, China) with 0.6 mm 13 
section thickness, TE = 160 ms, TR = 600 ms, 156 mm × 156 mm point resolution and 14 
one time excitation. The T1 relaxivity was measured by a linear fitting of the T1 15 
relaxation time (1/T1) as a function of the Gd3+ ions concentration. 16 
2.5. Cell culture 17 
The A549 cells (human non-small cell lung cancer cell) were chosen as modal cells 18 
in this study. DMEM medium with 10% FBS was used to incubate A549 cells at 37 °C 19 
with 5% CO2.  20 
2.6. Cytotoxicity and hemolysis assay 21 
MTT assay, The A549 cells viability was tested by the MTT assay to evaluate the 22 
cytotoxicity of the GNCNs. Briefly, the cells were seeded into a 96-well plate (5×103 23 
cells/well ) and incubated in medium for 24 h. After that, the fresh medium containing 24 
GNCNs at different Au concentrations or PBS (control group) were used to replace the 25 
above medium, respectively. After 24 h and 48 h incubation, the medium was added 26 
with MTT (5 mg/mL, 20 mL) and maintained incubation for another 4 h, respectively. 27 
The cell viability was assessed refer to the previous report.[39] 28 
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Apoptosis assay, in briefly, A549 cells at 2.0 × 105 cells/well were seeded in 6-well 1 
plates for 24 h. Then, the cells were incubated with GNCNs at different Au 2 
concentrations or PBS (control group) for 24 h. The distributions of necrotic or 3 
apoptotic cells induced by GNCNs were measured on the basis of the manufacturer’s 4 
protocol of Annexin V-FITC/PI apoptosis detection kit. The flow cytometry (BD 5 
FACSCalibur, BD Biosciences, USA) was used to measure the apoptosis of GNCNs 6 
treated cells. The data were analyzed by FlowJo 7.6 software. 7 
Hemolysis assay, the fresh human blood was centrifuged at 1000 rpm for 10 min to 8 
remove the supernatant. Then, the blood was washed with PBS for 5 times to acquire 9 
the red blood cells (HRBCs). The HRCBCs suspension (0.1mL) was diluted into 0.9 mL 10 
PBS (negative control group), 0.9 ml water (positive control group), or 0.9 mL GNCNs 11 
PBS solution at different Au concentrations (22-550 µM), respectively. The mixtures 12 
were reacted at room temperature for 2 h, after a gentle shaking. After that, the mixtures 13 
were centrifuged at 10000 rpm for 1 min. The absorbance of the supernatants at 541nm 14 
and the photos of the mixtures were recorded to measure the hemolysis of GNCNs. The 15 
hemolysis percentages = (OD541 nm of the experiment group - OD541 nm of the 16 
negative control group)/(OD541 nm of the positive control – OD541 nm of the negative 17 
control group )×100%.  18 
2.7. Cellular uptake assay 19 
Confocal microscopy experiments, A549 cells (2.0 × 104 cells/well) were seeded in 20 
coverglass in 24-well plates. After 24 h incubation, the cells were co-incubation with 21 
GNCs or GNCNs at Au concentration of 550 µM for 4 h and 10 h, respectively. After 22 
two times washed with PBS, the cells were fixed by the 2.5% glutaraldehyde for 30 min 23 
at 4 °C. Then Hoechst 33342 was used to stain nuclei at room temperature for 15 min. 24 
The nuclei was detected by the blue diode 405 nm laser. And the GNCNs and GNCs 25 
were excited at 620 nm on the TCS SP8 confocal laser scanning microscope.  26 
Flow cytometry (FCM) measurements, A549 cells (2.0 × 105 cells/well) were plated 27 
onto 6-well plates and cultured in medium for 24 h. Then, the cells were treated with 28 
GNCs or GNCNs at Au concentration of 550 µM for 4 h and 10 h, respectively. FL3 29 
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channel was used to measure the amount of GNCs or GNCNs in A549 cells, 1 
respectively. 2 
ICP-MS measurements, similar to the steps of FCM measurements, the A549 cells 3 
were collected and then digested by aqua regia before quantifying by ICP-MS. Besides, 4 
the A549 cells were also co-incubated with GNCNs or GNCs at different Au 5 
concentrations ([Au] = 0-550µM) for 10 h to test the cell uptake efficiency by ICP-MS. 6 
2.8. In vitro NIRF/CT/MR imaging 7 
Approximately 2×106 A549 cells were seeded in 5 mL cell culture flask and then 8 
were incubated for 24 h. After that, the cells were co-incubated with 2 mL fresh medium 9 
containing GNCNs or GNCs at different Au concentrations ([Au] = 0-550 µM). After 10 10 
h incubation, the cells were resuspended in 100 µL PBS and placed in 1.5 mL 11 
Eppendorf tubes. The in vivo tumor CT imaging studies were conducted with 12 
dual-source CT system. The T1-weighted MR imaging of the A549 cells incubation 13 
with the GNCNs was measured by a 3.0 T clinical MR imaging instrument (SOMATON 14 
Definition Flash, Siemens, Erlangen, Germany). MR images of A549 cells were 15 
acquired with slice thickness = 0.7 mm, TR = 280 ms, TE = 15 ms, 318×314 matrix and 16 
80×100 FOV. The signal to noise ratio (SNR) (T1-weighted MRI signal intensity of the 17 
tumor area/T1-weighted MRI signal intensity of air area) was calculated to quantify the 18 
T1-weighted MRI effect of the GNCNs. For in vitro NIRF imaging, A549 cells (5×103 19 
per well was pelted in 96-well plates) were incubated with GNCNs or GNCs (at the 20 
same Au concentrations for CT/MR imaging) for 10 h. Then, the Bruker In-Vivo F PRO 21 
imaging system (Billerica, USA) was used to obtain fluorescence images with 22 
excitation: 530/20 nm, emission: 700/30 nm and integration time: 20 s. 23 
2.9. In vivo NIRF/CT/MR imaging 24 
Female and male BALB/c-nude mice (4 weeks of age) were obtained from 25 
Shanghai Slac Laboratory Animal Co., Ltd. According to the Institutional Animal Care 26 
and Use Committee of Shanghai Jiao Tong University, all animals received care. In the 27 
right flank regions of mice, 4 × 106 A549 cells/mouse were subcutaneously injected to 28 
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establish A549 tumor model. The volume of tumors were allowed to reach ∼200 mm3 1 
before the NIRF/CT/ MR imaging.  2 
For the CT imaging, the mice were randomly allocated into 2 groups. Mice in 3 
group 1 were intravenously injected with GNCs. Mice in group 2 were intravenously 4 
injected with GNCNs (both containing 0.11 M Au, 150 µL per mouse). The CT 5 
scanning was executed at different time points by using a dual-source CT system. For 6 
MR imaging, the mice were given tail intravenous injection with the GNCNs ([Gd] = 7 
5mM, 150 µL per mouse). The T1-weighted MR imaging of the mice was carried out by 8 
using a 3.0 T clinical MR imaging instrument. Moreover, at preset time points, the 9 
fluorescence images were acquired after the mice were intratumoral injected with the 10 
GNCs or GNCNs ([Au] = 0.11 M, 50 µL per mouse), by using a Bruker In-Vivo F PRO 11 
imaging system (Billerica, USA). The mice were sacrificed and the tumors and main 12 
organs were extracted for ex vivo NIRF imaging at 24 h post-injection,. The Bruker 13 
Molecular Imaging Software 7.1 Version was used to quantify the average fluorescence 14 
intensity of the excised organs and tumor. 15 
2.10. In vivo biodistribution of GNCNs  16 
For in vivo biodistribution studies of GNCNs, the A549 tumor bearing mice were 17 
caudal vein injected with GNCNs ([Au] = 0.11 M, 150 µL per mouse). After 20 min, 60 18 
min and 6 h post injection, the mice were sacrificed and the main organs (heart, spleen, 19 
lung, kidney, and liver), blood and tumors were extracted and weighed, respectively. 20 
The gold and gadolinium elements content in organs, blood and tumors were analyzed 21 
by ICP-OES, after digesting the extracted samples in aqua regia solution overnight.  22 
2.11. In vivo security evaluation 23 
Blood analysis, the BALB/c female mice were intravenously injected with GNCNs 24 
([Au] = 0.11 M, 300 µL per mouse). The weight was measured for 21 days after 25 
intravenous injection. 500 µL of blood was collected and separated before and after 7 26 
days and 21 days of intravenous injection, respectively. The indicators of kidney 27 
function (creatinine (CREA), urea nitrogen (BUN) and uric acid (UA) ) and liver 28 
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function (lactate dehydrogenase (LDH), alkaline phosphatase (ALP), gamma glutamyl 1 
transferase (GGT), total bilirubin (TBIL) and aspartate aminotransferase (AST)) were 2 
tested by standard biochemical examination.  3 
For the histochemical analysis, the main organs (liver, lung, spleen, heart, and 4 
kidney ) were harvested before and after 21 days of tail intravenous injection of GNCNs. 5 
Then hematoxylin and eosin (HE) staining assay were performed to detect the change in 6 
morphological features of each organ. 7 
2.12. Statistical analysis  8 
All data were expressed as mean ± SD (Standard Deviation) of at least three 9 
independent experiments unless otherwise specified. 10 
3. Results and discussions 11 
3.1. Synthesis and characterization of GNCs and GNCNs 12 
The TBAB-reduction method [24, 40] was used to synthesize red-emitting and 13 
glutathione (GSH)-capped gold nanoclusters (GNCs), with a main fluorescence peak at 14 
652 nm. The monodispersed spherical GNCs (with a GSH-to-Au atom ratio of 0.82) had 15 
a diameter of about 2.0 nm (Fig. S1A) and also possessed high GSH content on their 16 
surface [24, 29]. It has been reported that the pKa of the glutathione (GSH) moiety was 17 
below 4 [41]. Following this statement, all of the surface carboxylic groups would be 18 
deprotonated under neutral conditions leading to the GNCs to acquire a negative 19 
charged surface [38]. Thus, the positively charged Gd3+ ions could bind to the 20 
negatively charged GNCs by both strong electrostatic interactions and coordination 21 
effects, in aqueous solution [22, 42]. 22 
Gd3+ ions in aqueous solution were added dropwise to the aqueous solution of 23 
GNCs in different concentrations to obtain assembled GNCs (GNCNs). The 24 
morphology and size of the GNCNs were characterized by TEM. Since the Gd3+ ions 25 
were electrostatically bound to the carboxyl groups of the GSH on the surface of the 26 
GNCs, the size and morphology of the assembled GNCs would depend on the molar 27 
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ratio of Gd3+ ions to GSH (designated as R[Gd3+]/[GSH]). As shown in the inset in Fig. S1A, 1 
when no Gd3+ ions were added (R[Gd3+]/[GSH] = 0), the monodispersed GNCs with 2 
spherical shape gave a brownish color to the solution and revealed a good dispersion in 3 
aqueous solution. If the R[Gd3+]/[GSH] was increased to 0.05, the Gd3+ ions began to induce 4 
the assembly of the GNCs. Under these conditions, partially assembled GNCs with 5 
small spherical shapes appeared in the TEM images (Fig. S1B). Meanwhile, the status 6 
of the assembled GNCs solution displayed no visible change (inset in Fig. S1B), 7 
compared with that of the free GNCs. This may be attributed to a lack of Gd3+ ions, 8 
which act as the bridge to induce the assembly of GNCs [38]. Uniformed and 9 
monodispersed spherical assembled GNCs were observed in TEM images when 10 
R[Gd3+]/[GSH] was increased to 0.08 (Fig. S1C). Under these conditions, the solution 11 
containing the assembled GNCs revealed a translucent light fawn color and showed 12 
excellent water solubility (insets in Fig. S1C). At a R[Gd3+]/[GSH] value of 0.11, an 13 
aggregation generated from irregularly assembled structures appeared in the TEM 14 
images (Fig. S1D). The aqueous solution of the assembled GNCs became turbid and 15 
showed tawny color, which confirmed that the aggregations were successfully generated 16 
(inset in Fig. S1D). The occurrence of the aggregation was formed by bridging the 17 
individual GNCNs together under the condition of excessive Gd3+ ions. The size of the 18 
assembled GNCs increase with the R[Gd3+]/[GSH] value was corroborated by the 19 
enhancement of the absorbance value observed by UV-Vis spectroscopy (Fig. S2A) [43]. 20 
The two main effects of the counter cations influencing on the assembly of GNCs have 21 
been recently reported by Yao et al.[38] and can be summed up as decrease in the 22 
negative charge on the GNCs and the subsequent bridging of the GNCs. This 23 
explanation matches with the increase in the zeta potential of the aqueous solution of 24 
GNCNs (pH≈6.5) with the concentration of Gd3+ ions (Fig. S2B). As a consequence, the 25 
GNCs were assembled at an optimal R[Gd3+]/[GSH] value of 0.08 for their future 26 
application in tumor diagnosis. 27 
The morphology and composition of assembled GNCs at R[Gd3+]/[GSH] of 0.08 were 28 
also tested by HR-TEM. As shown in Fig. 1A and B, the diameter of GNCs was about 2 29 
nm and they could be plain visualized inside the assembled GNCNs. The SEM images 30 
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with the corresponding results indicated that the GNCNs were almost uniform spheres 1 
with good monodipersity (Fig. 1C and Fig. S3). The narrow hydrodynamic diameter 2 
distribution around 200 nm of the GNCNs in aqueous solution measured by DLS (Fig. 3 
1D) not only confirmed the results of TEM and SEM but also indicated that the GNCNs 4 
may preferentially enter the tumor tissue by the Enhanced Permeability and Retention 5 
(EPR) effect [44]. As previously reported, the ultrasmall metal GNCNs can be 6 
considered as a new family of ion mimics (‘‘nanoions’’) [38]. The high order of 7 
regularity of the assembled GNCs may be due to the selectively induced electrostatic 8 
interactions in the assembly of the GNCs, which is similar to the formation of ionic 9 
crystals from real ions while different from the random aggregation of counter 10 
ions-mediated nanoparticles [38]. Moreover, elemental line-scanning EDX and mapping 11 
EDX analysis were performed to further demonstrate the chemical composition and the 12 
atomic distribution of the GNCNs [45, 46]. Fig. 2A showed a linear distribution of 13 
elemental Au and Gd across the diameter of a typical assembly, where the concentration 14 
of Au was clearly higher than that of the Gd in the entire region of the GNCNs. In order 15 
to further research the elemental spatial distribution of Au and Gd in GNCNs, elemental 16 
mapping of EDX analysis was carried out throughout a representative sample of 17 
GNCNs, as depicted in Fig. 2A. The two recognizable signals of elemental Au and Gd 18 
were distributed uniformly in the whole volume of GNCNs, as shown in Fig. 2B-D. By 19 
combining these data with EDX spectrum analysis (Fig. 2E), the exact composition of 20 
the spherical assembly was determined. We can infer that the GNCNs were indeed 21 
formed by the assimilation of GNCs with Gd3+ ions. The fluorescence excitation of the 22 
GNCs and GNCNs were depicted in Fig. S4 and Fig. 3A. The addition of Gd3+ ions had 23 
a strong effect on the physical and chemical properties of the GNCs with an 24 
enhancement in the optical luminescence accompanied by a blue shift of the emission 25 
peak. The fluorescence intensity of GNCNs at an optimal R[Gd3+]/[GSH] of 0.08 was 26 
almost 1-fold enhanced when compared with that of the GNCs (Fig. 3A). The increase 27 
of the optical luminescence of the GNCNs may be caused by the significantly shortened 28 
distance between the GNCs after their assembly, sequentially increasing the 29 
inter-cluster aurophilic interaction [47, 48] and reducing the non-irradiative relaxation 30 
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of excited electrons [48, 49]. In contrast, the fluorescence intensity was decreased at a 1 
higher R[Gd3+]/[GSH] value of 0.11, which may be due to the sedimentation of aggregated 2 
nanoparticles [22].  3 
3.2. Stability, cytotoxicity and hemolysis assay of the GNCNs  4 
It is crucial to test the stability of GNCNs before they are used in biomedical 5 
applications. Herein, the stability of the nanoparticles was further confirmed by TEM, 6 
UV-Vis, and DLS. The hydrodynamic diameter of the GNCNs revealed minor 7 
fluctuations within a period of one month, suggesting that the GNCNs have a good 8 
colloidal stability and can be stored in aqueous solution without noteworthy 9 
disaggregation or aggregation for a relatively long period of time (Fig. 3B). As shown in 10 
Fig. S5A, with the exception of a slight change in the smoothness of the surface, there 11 
was no observable agglomeration or disaggregation of GNCNs in the TEM images after 12 
being stored in aqueous solution for one month, which visually confirmed the stability 13 
of the GNCNs. Furthermore, the absorption features of the UV-Vis spectra of GNCNs at 14 
different temperatures in aqueous media solution showed no detectable variation (Fig. 15 
S5B), indicating that the GNCNs nanoprobes are stable in a temperature range of 16 
4-50 °C [50, 51]. Finally, no clear precipitation or state change were observed in the 17 
GNCNs solution after being exposed to PBS (pH=7.4) for two weeks (Fig. S5C). 18 
Although the results of Z-potential of the GNCNs in aqueous solution was very low, the 19 
observed stability of the GNCNs may be due to the surface glutathione endowing the 20 
GNCNs with a high steric hindrance. These results proved that GNCNs are stable, 21 
which is a basic feature for their future application on the biomedical field. 22 
The cytocompatibility of the GNCNs is also a crucial indicator to test their 23 
potential for biomedical imaging applications. The cell viability was evaluated by MTT 24 
assay to assess the cytocompatibility of the GNCNs (Fig. 4A). In comparison with the 25 
control cells incubated with PBS, the viability of A549 cells had no appreciable change 26 
after 24 h treatment with the GNCNs in a concentration range of 0-550 µM of Au. After 27 
incubation with the GNCNs for 48 h, the GNCNs start to display a slight cytotoxicity at 28 
Au concentrations higher than 220 µM. The MTT results inferred that the GNCNs were 29 
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cytocompatible at the studied concentration. Moreover, the apoptosis assay of A549 1 
cells exposed to GNCNs at different Au concentrations was measured by flow 2 
cytometry, revealing similar results to those of the MTT assay, as shown in Fig. S6. 3 
Hemocompatibility is an important issue in blood-contacting applications of 4 
nanoparticles. Hemolysis assays were performed to examine the hemocompatibility of 5 
the GNCNs before their use as contrast agents for tumor multi-modality imaging, in 6 
vivo (Fig. 4B). The absorbance at 541 nm of the supernatant in the UV-Vis spectra was 7 
measured to quantify the hemolysis percentages of the GNCNs at different Au 8 
concentrations (0–550 µM). The GNCNs do not show obvious hemolytic effects at the 9 
measured Au concentrations, when compared with the positive control. The results 10 
showed that even at the maximum concentration of element Au, the hemolysis 11 
percentage of GNCNs is less than the threshold value of 5% with the highest hemolysis 12 
percentage reaching 3.15%, suggesting an excellent hemocompatibility in the studied 13 
concentration range and enabling the GNCNs to be used for future in vivo tumor 14 
multi-modality imaging.  15 
3.3. T1 MR relaxometry and X-ray attenuation 16 
With the co-existence of GNCs and Gd3+ ions, the formed GNCNs possess X-ray 17 
attenuation and T1 MR relaxivity properties for CT and MR imaging applications, 18 
respectively. Herein, the X-ray attenuation property and T1 MR relaxometry of the 19 
GNCNs were measured prior to in vivo multi-modality imaging studies. The brightness 20 
change in the CT images of GNCs, GNCNs and Omnipaque (iodine-based CT contrast 21 
agent) in various concentrations of Au or iodine revealed that the CT contrast 22 
enhancement was improved with the increase of Au or iodine concentrations (Fig. 5A). 23 
It was obvious that the brightness of the CT images and the attenuation intensity of 24 
GNCNs were higher than that of free GNCs at the same Au concentrations (Fig. 5B). 25 
That may be caused by the existence of Gd3+ ions, which probably contribute to a small 26 
contrast enhancement of the CT images of GNCNs [52, 53]. Compared with the 27 
Omnipaque, the enhanced X-ray attenuation property of GNCNs and GNCs may be 28 
caused by the X-ray absorption coefficient of Au is higher than that of I [4]. In addition, 29 
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with the increase of the concentration of Gd3+ ions, a concentration-dependent signal 1 
enhancement appeared in the T1-weighted MR images of DTPA-Gd and GNCNs (Fig. 2 
5C). It was clear that the signal enhancement intensity of the GNCNs was better than 3 
that of the T1 contrast agent Magnevist (DTPA-Gd) at the same Gd3+ ions concentration. 4 
Simultaneously, the transverse relaxivity (r1) value of GNCNs was 24.64 mM−1 S−1, 5 
which was about 4.3 times higher than that of the Magnevist (4.68 mM−1 S−1), implying 6 
a superior contrasting ability of GNCNs in T1-weighted MRI (Fig. 5D). In the GNCNs 7 
system, compared with that of the gadolinium chelated in Magnevist, the local 8 
concentration of Gd3+ ions was increased and the tumbling and rotational rate of Gd3+ 9 
ions was reduced, which may give a higher relaxivity value to GNCNs than that of the 10 
Magnevist [9, 36, 54, 55]. In a word, the GNCNs possess an enhanced fluorescence, 11 
reasonable T1 relaxivity and highly X-ray attenuation. These properties enable them to 12 
act as a new candidate for NIRF/CT/MR imaging applications.   13 
3.4. In vitro cellular uptake 14 
The cellular internalization of GNCNs and GNCs in A549 cells was quantified and 15 
visually analyzed by flow cytometry (FCM) and confocal laser scanning microscopy 16 
(CLSM), respectively (Fig.6). As shown in Fig. 6A, blue fluorescence was used to 17 
localize the cell nuclei using Hoechst 33342 dye, while the GNCNs and GNCs were 18 
detected by their intrinsic red fluorescence. Similarly to the behaviors of GNCs, the 19 
GNCNs were mainly accumulated in the cytoplasm after endocytosis [24]. The 20 
efficiency of the uptake of the GNCNs and GNCs in A549 cells was clearly increased 21 
with a prolonged incubation time. For the GNCs, only a slight red fluorescence was 22 
detected, after 4 h of incubation with the A549 cells, implying that a small quantity of 23 
GNCs were internalized into the cells. On the other hand, a relatively strong red 24 
fluorescence already appeared in the cytoplasm after the A549 cells were treated with 25 
the GNCNs for 4 h. This phenomena was confirmed by the results of FCM (Fig.6B and 26 
Fig.6C), where the mean fluorescence intensity of the A549 cells treated with the 27 
GNCNs was 2.9 times higher than that of the GNCs incubated groups (Fig.6B). When 28 
the incubation time was prolonged to a total of 10 h, the amount of internalized GNCs 29 
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slightly increased. Under the physiological pH range, the surface zwitterionization of 1 
the GNCs may reduce the cellular affinity of GNCs, which may be the cause of the 2 
lower efficiency in the cellular uptake [29, 56]. In contrast, a remarkable increase of red 3 
fluorescence was detected in the cytoplasm of A549 cells after prolonging the 4 
incubation time with GNCNs to 10 h, which indicated a clear uptake enhancement of 5 
GNCNs compared with GNCs. One explanation of the increase in the cellular uptake of 6 
GNCNs may be due to the changes in their surface upon addition of Gd3+ ions. In this 7 
way, the linkage of the negatively charged carboxylic groups to the Gd3+ ions may 8 
induce the nanoparticles to change from a zwitterionic to a non-zwiterionic surface and 9 
also change their surface charge [57, 58]. Additionally, the mean fluorescence of the 10 
cells treated with GNCNs measured by FCM was approximately 5.1-fold higher than 11 
the corresponding cells incubated with GNCs, after being incubated for 10 hours 12 
(Fig.6B). Overall, the results of CLSM were consistent with those obtained by FCM, 13 
which suggested that the assembled GNCNs would improve the cell internalization of 14 
GNCs. More importantly, ICP-MS analysis was also carried out to quantify the 15 
intracellular content element of Au in A549 cells treated with GNCNs or GNCs after 4 h 16 
and 10 h of treatment, respectively. The results further proved that the GNCNs exhibited 17 
an excellent cellular uptake efficiency, compared to GNCs (Fig. S7).  18 
3.5. In vitro multi-modality imaging of cancer cells 19 
The multi-modality imaging ability of GNCNs was also explored in this study 20 
using A549 cancer cells. The cells were cultivated with GNCs or GNCNs at different Au 21 
or Gd3+ ion concentrations for 10 h before performing the multi-modality imaging. 22 
Their CT/MR/NIRF imaging capabilities were quantified by measuring the CT value, 23 
signal to noise ratio (SNR) and average fluorescence intensity, respectively. For the 24 
T1-weighted MRI, an obvious increase was observed in both the brightness and the 25 
signal to noise ratio (SNR) of T1-weighted cells MR images of GNCNs with the 26 
increase of the Gd3+ ions concentration (Fig. S8A and S8B), which were remarkably 27 
higher than those of PBS-incubated controls. Similarly to the T1-weighted MRI, the 28 
NIRF imaging ability of GNCNs or GNCs depends on the concentration of Au (Fig. 29 
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S9A). The average fluorescence intensity of the cells treated with GNCNs was higher 1 
than that of GNCs treated groups at the same Au concentrations, suggesting that the 2 
GNCNs were easier to uptake by A549 cells than that of GNCs (Fig. S9B). Unlike with 3 
MR and NIRF images of GNCNs treated cells, the brightness difference of the CT 4 
images of the cells treated with GNCNs or GNCs was not easily distinguishable by 5 
naked eye at various of Au concentrations (Fig. S8C) [8, 18]. Therefore, the CT values 6 
of the GNCs and GNCNs treated cells were measured with the manufacture’s standard 7 
display program to detect the cells CT imaging effect of GNCs and GNCNs. As shown 8 
in Fig. S8D, the CT values of cells treated with either GNCNs or GNCs increased with 9 
the Au concentrations. A higher CT value was observed in the GNCNs treated cells than 10 
in the GNCs treated ones, confirming the enhancement of the cells uptake efficiency 11 
and the high X-ray attenuation property of GNCNs. The above conclusions were 12 
verified by ICP-MS results, in which the Au content in A549 cells treated with GNCNs 13 
was higher than that of GNCs at different Au concentrations after 10 h incubation (Fig. 14 
S10A). 15 
3.6. In vivo tumor multi-modality imaging 16 
To explore the possibility of GNCNs as an imaging contrast agent for clinical 17 
cancer diagnosis, the potential performance of GNCNs for multi-modality imaging was 18 
carefully evaluated by applying MR/CT/NIRF imaging techniques in mouse models 19 
with A549 xenografted tumor. For T1-weighted MRI, Fig. 7A showed that the 20 
brightness of the tumor areas remarkably heightened after injection of GNCNs. The 21 
quantified T1-weighted MRI signal intensity based on signal to noise ratio (SNR) 22 
approximately increased one time at 20 min post-injection in the tumor area, and the 23 
higher MRI signal lasted for 60 min (Fig. 7B). These observations suggested that the 24 
GNCNs can rapidly accumulate in the tumor area thanks to the passive EPR effect [59]. 25 
Thus, there is no remarkable influence on the application of the GNCNs for 26 
multi-modality cancer diagnosis, even if the selectivity of GNCNs towards cancer cells 27 
was low (Fig S10B). Meanwhile, CT imaging of the tumor area exhibited a remarkable 28 
contrast enhancement as well as T1-weighted MRI results after intravenous injection of 29 
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GNCNs or GNCs, which would be attributed to entire diffusion of the nanoparticles in 1 
the tumor via EPR effect (Fig. 7C and Fig. S11). Moreover, the CT value of the tumor 2 
area also reached a maximum at 20 min post-injection. Nevertheless, the CT value of 3 
the tumor area was higher with GNCNs than with GNCs at the same time points, 4 
inferring that the GNCNs possess a better CT imaging ability than GNCs in vivo (Fig. 5 
7D). 6 
By utilizing the intrinsic red-emitting ability of the GNCs under laser irradiation, 7 
the GNCNs and the GNCs were used in NIRF imaging applications. After intratumoral 8 
injection, the amounts of GNCNs or GNCs accumulated in the tumor areas were tested 9 
by analyzing the fluorescence signal intensity distribution around the tumors (Fig. 8A 10 
and B). The enhanced signal and intensity around the tumors of GNCNs treated mice 11 
post-injection (0 h) may be attributed to the high luminescence intensity of GNCNs, 12 
which was higher than that of free GNCs at the same Au concentrations. Moreover, the 13 
reduction of the fluorescence signal intensity around the tumor at 2, 6, 12 and 24 hours 14 
post-injection was much slower in the case of the mice injected with GNCNs than the 15 
corresponding results of the GNCs. These observations confirmed the results of CT/MR 16 
imaging, further suggesting that the assembly of GNCNs possess tumor longer retention 17 
times than that of GNCs by the passive targeting of EPR effect. Moreover, ex vivo NIRF 18 
imaging (Fig. 8C and D) results indicated that most of the GNCNs were accumulated in 19 
the tumor, followed by liver, kidney and lung, 24 h after intratumoral injection of 20 
GNCNs. Meanwhile, the averaged fluorescence intensity of the GNCNs in the tumor 21 
sites was much higher than that of free GNCs. To sum up, the inescapable conclusion is 22 
that the prepared GNCNs have a great potential as multifunction contrast agent for 23 
clinical cancer MR/ CT /NIRF imaging.  24 
The biodistribution of GNCNs based on ICP-MS (Fig. S12) revealed that the 25 
elemental distribution of Au in the different organs was similar to that of Gd3+ ions in 26 
the mice post-injection of GNCNs, further suggesting that the GNCNs were formed by 27 
the assimilation of GNCs with Gd3+ ions rather than as a result of a mixture of the 28 
GNCs and Gd3+ ions. The ICP-MS results also indicated a fast urine elimination of 29 
GNCNs, as the GNCNs were significantly accumulated in the kidney post-injection and 30 
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were almost cleared from the kidney with a prolonged circulation time of 6 h. Future 1 
study is needed to improve the surface modification of the GNCNs aiming to increase 2 
their blood circulation time. Moreover, a small amount of Au and Gd remained in heart, 3 
liver, spleen, and lung post-injection, suggesting a low uptake of the GNCNs by the 4 
Reticulo-Endothelial System (RES) tissues and that the GNCNs were not significantly 5 
retained in the lung [54]. These observations indicated that the GNGNs are safe for in 6 
vivo biomedical imaging applications. 7 
3.7. In vivo security evaluation 8 
The in vivo security evaluation of imaging contrast agents is crucial for their use in 9 
clinical disease diagnosis. In this study, the body weight change, blood biochemistry 10 
analysis and HE-stained histology were performed to assess the in vivo safety of the 11 
GNCNs as contrast agents for multi-modality imaging. The HE stained slices of main 12 
organs (e.g., lung, heart, liver, spleen and kidney) showed no noticeable abnormality or 13 
lesion after 21 days post-injection of GNCNs (Fig. S13). The weight change is one of 14 
the main indicators of organism intoxication [39]. As shown in Fig. S14, no significant 15 
body weight loss was detected in the GNCNs treated mice and there was no death of 16 
mice in the whole time period of the experiment. Moreover, to further verify whether 17 
the GNCNs would cause damage of the liver and kidney, where the most of exogenous 18 
substances are metabolized and cleared, a blood biochemistry of main liver and kidney 19 
indicators was analyzed 7 and 21 days after intravenously injection of GNCNs. As 20 
shown in Fig. S15, neither the liver function indicators nor the kidney function revealed 21 
any significant toxicity symptoms in the GNCNs injected groups compared to that of 22 
the normal control groups [40]. All of the abovementioned data demonstrated that the 23 
GNCNs would not induce any injury to the organs and that they can be safely applied in 24 
clinic cancer imaging as contrast agents. 25 
4. Conclusion 26 
In this study, the gold nanoclusters (GNCs) were assembled into monodisperse 27 
spherical particles (GNCNs) in aqueous solution for enhanced tumor multi-modality 28 
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imaging by selectively inducing electrostatic interactions between trivalent cations of 1 
gadolinium and negatively-charged carboxyl groups on the GNCs. By this simple, 2 
time-saving assembly approach, the Gd3+ ions can be chelated into the GNCNs without 3 
using molecular gadolinium chelates, giving GNCNs regular morphology and enhanced 4 
photoluminescence properties under mild conditions. Compared with free GNCs, the 5 
resulting GNCNs have good biocompatibility both in vitro and in vivo and can be easily 6 
internalized by the A549 cells. With the co-existence of GNCs and Gd3+ ions, the 7 
GNCNs could be used as a multifunctional nanoplatform for NIRF/CT/MR imaging of 8 
A549 cancer cells in vitro and of xenografted A549 tumor models in vivo. Therefore, the 9 
multifunctional GNCNs hold great promise in clinic cancer diagnosis. In addition, this 10 
study may provide some guidelines for the assembly of other hydrophilic ultrasmall 11 
nanoparticles modified with carboxyl-containing surfaces, such as carbon dots and 12 
quantum dots. Such guidelines have the potential to broaden the application of these 13 
ultrasmall nanoparticles in cancer diagnosis. 14 
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Scheme 1. Schematic illustration of gadolinium (Gd3+) ions-mediated self-assembly of gold 
nanoclusters (GNCs) into monodisperse spherical nanoparticles (GNCNs) for multi-modality cancer 
diagnosis under mild conditions. 
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Fig. 1. Characterizations of the GNCNs. (A) TEM image of the GNCNs. (Inset) the amplified TEM 
image of the GNCNs. (B) HR-TEM image of the GNCNs. (C) SEM image of the GNCNs. (Inset) 
amplified SEM image of the GNCNs. (D) DLS curve shows the diameter distribution of the GNCNs. 
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Fig. 2. (A) STEM image of a typical assembly (GNCNs). (B–C) The mapping EDX analysis of 
distribution of Au (B) and Gd (C) elements in a typical assembly in (A). The insets in (B) and (C) 
display the elemental line-scanning EDX analysis of Au (red curve) and Gd (green curve), 
respectively. (D) Shows the superimposing image of (B) and (C). (E) Shows the EDX spectrum 
analysis of the content of the Au and Gd elements of the typical assembly in (A). 
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Fig. 3. (A) Fluorescence spectra of the GNCs and the GNCNs (λex = 520 nm). (Inset) Digital 
pictures of GNCs (left) and GNCNs (right) dissolved in aqueous solution under UV(365 nm) 
excitation. (B) Colloid stability test of GNCNs in aqueous solution (mean ± SD, n =3). 
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Fig. 4. (A) A549 cells viability measured by MTT assay after incubation with PBS (as control) and 
the GNCNs at different Au concentrations for 24 h and 48 h, respectively (mean ± SD, n =3). (B) 
Hemolytic activity of GNCNs at different Au concentrations. The bottom-right inset and the 
upper-right inset represent the photograph of HRBCs and the enlarged UV−Vis absorption of the 
supernatant after the blood incubation with water, PBS and GNCNs PBS solution at different Au 
concentrations for 2 h, respectively. 
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Fig. 5. X-ray attenuation property and T1 MR relaxometry of the GNCNs. (A) CT images and (B) 
X-ray attenuation intensity of GNCs, GNCNs and Omnipaque (O) at different Au or I concentrations, 
respectively. (C) T1-MR images of Gd-DTPA and GNCNs. (D) The linear fitting of the inverse T1 of 
Gd-DTPA and GNCNs as a function of Gd3+ ion concentration. 
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Fig. 6. Cellular uptake of GNCNs by A549 cells. (A) Confocal images of the A549 cells treated with 
GNCNs or GNCs for 4 and 10 h, respectively. Scale bar, 100 µm. (B) Flow cytometry analysis of the 
A549 cells incubated with GNCNs or GNCs for 4 and 10 h, respectively. Mean: mean fluorescence 
of M2 subset. (C) The population distribution histogram of A549 cells with GNCs or GNCNs (mean 
± SD, n = 3).  
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Fig. 7. In vivo X-ray CT/MR imaging. (A) In vivo T1-weighted MR images of A549 tumor-bearing 
mice post intravenous injection of GNCNs at different time points. (B) T1 signal to noise ratio 
around the tumors of (A). (C) CT images of A549 tumors-bearing mice post intravenous injection of 
GNCs or GNCNs at different time points. (D) CT values around the tumors of (C). The arrows point 
indicate the location of the tumor area (mean ± SD, n =3). 
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Fig. 8. In vivo NIRF imaging and biodistribution of the A549 tumor-bearing mice post intratumoral 
injection of GNCNs or GNCs. (A) In vivo time-dependent NIRF imaging of A549 tumor-bearing 
nude mice. (B) The average fluorescence signal intensities around the tumors of (A) (mean ± SD, n 
=3). (C) In vitro biodistribution of the extracted main organs and tumors at 24 h post intratumoral 
injection of GNCNs or GNCs. (D) The average fluorescence intensities of (C) (3 mice/group). 
 
